{"name":"Therapex Co., Ltd","slug":"therapex-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPUjc5LVJ4dnJkdWdPVElCNjY3SnBHWUV1WHI1akpCRE44WnFTN2k0ckFjeG52Y2lhQzN6bjByMXpOU3hHUjBfVkxFSUpjN2xZSXhiaExGR2JoYnJIUWFTSUZZelcxZEFqd0JmNW9uVWtvN1dWV19vcFk3Y3dKQ2JqODR1d0hwRHVPWHFiMTAxX1JDUGc1VWFnLUZWNA?oc=5","date":"2026-03-24","type":"pipeline","source":"openPR.com","summary":"EGFR Non Small Cell Lung Cancer Pipeline 2026: Key Companies, - openPR.com","headline":"EGFR Non Small Cell Lung Cancer Pipeline 2026: Key Companies,","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFB6M29GeEZLRmdobzFUUnZPc050Z0hSUHBTX211UWo0THZFRWZkd3MtUFFlNXhDZlNQSEFyWHlKeW1ueE16M0QxMEt2OHZHU2RLcnNGLVd3OTlpWnJXRFIzVVYtNEVrS2M5dzRoY1BB0gFyQVVfeXFMTWZ1NlplcmN6OW9rT2JCUXdfZXM1eFQwTnd2Yll0cm1odDFiVGZpenBWWndLamxVT3JkYk42VkZqMjZRekZxRFJBLVVFMGxYdEE3SUNNMi1WME5CcXRPSlh0N1FPZ0FIWE1yUVNaLV9wOVV3?oc=5","date":"2025-05-09","type":"pipeline","source":"koreabiomed.com","summary":"Therapex showcases competitive edge with DAC-based preclinical results - koreabiomed.com","headline":"Therapex showcases competitive edge with DAC-based preclinical results","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}